Legal Representation
Attorney
James M. Urzedowski
USPTO Deadlines
Next Deadline
2009 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-28)
Due Date
January 28, 2031
Grace Period Ends
July 28, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 28, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 28, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 7, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 7, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Dec 20, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 20, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 8, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 8, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 23, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 7, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 23, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 17, 2024 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 15, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jun 20, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 20, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 20, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 5, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 5, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 5, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 7, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 7, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 7, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 6, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 25, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 24, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 20, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of inflammation, immune-related diseases, gastroenterological illnesses, dermatological conditions and respiratory illnesses
First Use Anywhere:
Aug 12, 2024
First Use in Commerce:
Aug 12, 2024
Additional Information
Design Mark
The mark consists of a capitalized version of the letter E, slightly spaced apart from the right side or curved portion of the capitalized letter B which together form the visual impression of a capital B icon with a vertical line or space extending therethrough, the icon positioned above the words Edesa Biotech, wherein the vertical space or line of the icon is centered above the letter B of the word Biotech.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"